PRESS RELEASE published on 10/31/2023 at 15:16, 1 year 5 months ago PAION AG HAS FILED FOR THE OPENING OF INSOLVENCY PROCEEDINGS - PRELIMINARY INSOLVENCY ADMINISTRATOR APPOINTED
PRESS RELEASE published on 10/26/2023 at 12:50, 1 year 5 months ago EQS-Adhoc: PAION AG: Filing an application for the opening of insolvency proceedings
PRESS RELEASE published on 10/20/2023 at 07:30, 1 year 5 months ago PAION AG to issue approximately 4.8 million shares at EUR 1.90 per share in capital increase with subscription rights
PRESS RELEASE published on 10/19/2023 at 20:56, 1 year 5 months ago EQS-Adhoc: PAION AG to issue approximately 4.8 million shares in capital increase with subscription rights
PRESS RELEASE published on 10/13/2023 at 13:06, 1 year 5 months ago PAION AG announces fully underwritten rights issue with target gross proceeds of EUR 10 million
PRESS RELEASE published on 10/13/2023 at 12:57, 1 year 5 months ago EQS-Adhoc: PAION AG announces fully underwritten rights issue with target gross proceeds of EUR 10 million
PRESS RELEASE published on 09/28/2023 at 14:00, 1 year 6 months ago PAION ANNOUNCES SUBMISSION OF NEW DRUG APPLICATION FOR REMIMAZOLAM BY ITS LICENSEE MUNDIPHARMA IN JAPAN
PRESS RELEASE published on 09/18/2023 at 15:26, 1 year 6 months ago Original-Research: PAION AG (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE published on 08/31/2023 at 14:00, 1 year 7 months ago PAION receives UK MHRA approval of Byfavo® (remimazolam) for the induction and maintenance of general anesthesia in adults
PRESS RELEASE published on 08/30/2023 at 07:30, 1 year 7 months ago PAION AG reports financial results for the First Half-Year 2023
Published on 04/07/2025 at 00:05, 7 hours 9 minutes ago Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders
Published on 04/05/2025 at 01:50, 2 days 5 hours ago Battery X Metals Achieves Graphite Recovery Breakthrough in Partnership with Global Top 20 University in Controlled Trials
Published on 04/07/2025 at 07:03, 11 minutes ago Swiss Re to be appointed as co-investment manager of GAM's catastrophe bond and ILS fund range
Published on 04/07/2025 at 07:00, 14 minutes ago Julius Baer further streamlines its organisation to reinforce focus on clients and sustainable growth
Published on 04/06/2025 at 18:20, 12 hours 53 minutes ago EQS-Adhoc: QIAGEN N.V.: QIAGEN announces strong preliminary Q1 2025 results and updates full-year 2025 adjusted earnings per share outlook
Published on 04/06/2025 at 15:09, 16 hours 5 minutes ago EQS-Adhoc: DEUTZ acquires developer of electrification solutions UMS
Published on 04/04/2025 at 19:00, 2 days 12 hours ago PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 04/07/2025 at 07:01, 13 minutes ago bioMérieux obtient le marquage CE pour LUMED™ APSS™, une solution logicielle de pointe pour aider à prendre des décisions en matière de bon usage des antibiotiques
Published on 04/07/2025 at 07:01, 13 minutes ago bioMérieux obtains CE-marking for LUMED™ APSS™, a cutting-edge software solution to aid medical decision-making in Antimicrobial Stewardship
Published on 04/04/2025 at 19:18, 2 days 11 hours ago Mersen: Number of shares and voting rights as of March 31, 2025
Published on 04/04/2025 at 19:18, 2 days 11 hours ago Mersen : nombre d'actions et de droits de vote au 31 mars 2025
Published on 04/04/2025 at 18:17, 2 days 12 hours ago Reporting on share buyback transactions carried out between March 31 and April 3, 2025
